Real-world data of cardiovascular disease in patients with metabolic dysfunction-associated fatty liver disease based on medical claim database in Japan

被引：0
|
作者：
Yoneda, Masato [1 ]
Yamamoto, Takuma [2 ]
Honda, Yasushi [1 ]
Kobayashi, Takashi [1 ]
Nogami, Asako [1 ]
Iwaki, Keidai [1 ]
Kessoku, Takaomi [1 ]
Saito, Satoru [1 ]
Nakajima, Atsushi [1 ]
机构：
[1] Yokohama City Univ, Dept Gastroenterol & Hepatol, Yokohama, Kanagawa, Japan
[2] Kowa Co Ltd, Product Mkt Dept, Cardiovasc & Diabet, Tokyo, Japan
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2021年 / 36卷
关键词：
MAFLD; NAFLD; CVD; big data;
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
PP-0143
引用
收藏
页码：128 / 128
页数：1
相关论文
共 50 条
  • [31] Metabolic dysfunction-associated fatty liver disease: a year in review
    Alharthi, Jawaher
    Gastaldelli, Amalia
    Cua, Ian Homer
    Ghazinian, Hasmik
    Eslam, Mohammed
    CURRENT OPINION IN GASTROENTEROLOGY, 2022, 38 (03) : 251 - 260
  • [32] Cardiometabolic characterization in metabolic dysfunction-associated fatty liver disease
    Perdomo, Carolina M.
    Nunez-Cordoba, Jorge M.
    Ezponda, Ana
    Mendoza, Francisco J.
    Ampuero, Javier
    Bastarrika, Gorka
    Fruhbeck, Gema
    Escalada, Javier
    FRONTIERS IN MEDICINE, 2022, 9
  • [33] Epidemiology and diagnosis of metabolic dysfunction-associated fatty liver disease
    Fouad, Yasser
    Alboraie, Mohamed
    Shiha, Gamal
    HEPATOLOGY INTERNATIONAL, 2024, : 827 - 833
  • [34] The Efficacy of Tofogliflozin on Metabolic Dysfunction-Associated Fatty Liver Disease
    Goya, Takeshi
    Imoto, Koji
    Tashiro, Shigeki
    Aoyagi, Tomomi
    Takahashi, Motoi
    Kurokawa, Miho
    Suzuki, Hideo
    Tanaka, Masatake
    Kato, Masaki
    Kohjima, Motoyuki
    Ogawa, Yoshihiro
    GASTROENTEROLOGY INSIGHTS, 2022, 13 (01) : 20 - 26
  • [35] LIVERSTAT for risk stratification for patients with metabolic dysfunction-associated fatty liver disease
    Leow, Yong Wen
    Chan, Wah Loong
    Lai, Lee Lee
    Mustapha, Nik Raihan Nik
    Mahadeva, Sanjiv
    Quiambao, Ronald
    Munteanu, Mona
    Chan, Wah Kheong
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2024,
  • [36] Body Composition Analysis in Patients with Metabolic Dysfunction-Associated Fatty Liver Disease
    Onishi, Saori
    Fukuda, Akira
    Matsui, Masahiro
    Ushiro, Kosuke
    Nishikawa, Tomohiro
    Asai, Akira
    Kim, Soo Ki
    Nishikawa, Hiroki
    NUTRIENTS, 2023, 15 (18)
  • [37] Blood lactate levels are associated with an increased risk of metabolic dysfunction-associated fatty liver disease in type 2 diabetes: a real-world study
    Ma, Yi-Lin
    Ke, Jiang-Feng
    Wang, Jun-Wei
    Wang, Yu-Jie
    Xu, Man-Rong
    Li, Lian-Xi
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [38] Management of cardiovascular risk in patients with metabolic dysfunction-associated steatotic liver disease
    Mellemkjaer, Anders
    Kjaer, Mikkel Breinholt
    Haldrup, David
    Gronbaek, Henning
    Thomsen, Karen Louise
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2024, 122 : 28 - 34
  • [39] Disease severity assessment of metabolic dysfunction-associated fatty liver disease in Taiwan
    Huang, Jee-Fu
    Tsai, Pei-Chien
    Huang, Ching-I
    Yeh, Ming-Lun
    Huang, Chung-Feng
    Dai, Chia-Yen
    Yu, Ming-Lung
    JOURNAL OF HEPATOLOGY, 2022, 77 : S458 - S459
  • [40] Transition of an acronym from nonalcoholic fatty liver disease to metabolic dysfunction-associated fatty liver disease
    Shahinul Alam
    Shah Mohammad Fahim
    World Journal of Hepatology, 2021, 13 (10) : 1203 - 1207
12345